Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda guidance for industry cgmp for phase 1 | 1.52 | 0.8 | 9053 | 24 |
fda guidance phase 1 gmp | 1.75 | 0.9 | 8919 | 55 |
fda phase appropriate cgmps | 1.32 | 0.8 | 2424 | 67 |
cgmp for phase 1 investigational drugs | 0.07 | 0.6 | 3767 | 4 |
fda phase 1 gmp | 1.46 | 0.2 | 6156 | 24 |
cgmp guidelines for pharmaceutical industry | 1.58 | 0.6 | 1993 | 7 |
phase 1 gmp guidance | 1.38 | 0.1 | 4765 | 62 |
fda guidance for phase 1 | 0.4 | 0.8 | 3722 | 74 |
fda guidance for phase 1 manufacturing | 1.51 | 0.8 | 6191 | 15 |
us fda cgmp guidelines | 1.19 | 0.5 | 9173 | 78 |
cgmp for phase 2 investigational drugs | 0.78 | 1 | 4521 | 32 |
fda phase 1 cmc guidance | 1.05 | 0.9 | 6256 | 51 |
cgmp guidelines fda 21 cfr part 11 | 1.45 | 0.4 | 2738 | 73 |
phase 1 ind fda guidance | 0.14 | 0.9 | 5751 | 84 |
gmp for phase 1 | 1.89 | 0.2 | 3224 | 71 |
cgmps are regulations published by the fda | 1.44 | 0.1 | 5077 | 35 |
fda cgmp 21 cfr | 0.46 | 0.5 | 1733 | 23 |
cgmp regulations for pharmaceutical | 0.21 | 0.7 | 5596 | 3 |
fda-cgmp | 1.42 | 0.9 | 3320 | 48 |